Drug Delivery Business2 天
Glucotrack expects FDA IDE for implantable CBGM this year
Glucotrack (Nasdaq:GCTK) announced that it expects FDA investigational device exemption for its long-term CBGM later this ...
来自MSN6 个月
FDA Clears the First Implantable Continuous Glucose Monitor That Can Last a Year
the latest implantable continuous glucose monitoring (CGM) system for adults with diabetes that can last up to a year. The previous monitor, Eversense E3, could last up to six months without ...
Medical Design & Outsourcing8 天
Lessons from Medtronic’s Define AFib study of implantable cardiac monitors
Cardiac electrophysiologist Dr. Jonathan Piccini says Medtronic's Define AFib study offers important lessons for other device ...
pharmaphorum8 年
Senseonics' implantable glucose monitor passes test
Senseonics has revealed promising results for its Eversense technology, a long-term implantable continuous glucose monitoring (CGM) system. The PRECISE II trial looked at the safety and ...